DO ANDROGENS PREDICT CARDIOVASCULAR RISK INCLUDING CARDIOTROPHIN-1 LEVELS in PATIENTS WITH OBESE and LEAN POLYCYSTIC OVARY SYNDROME.

Yasar, H Y; Colak, A; Demirpence, M; Girgin, E; Aslan, F D; Taylan, A; Ceylan, C

Yasar, H Y; Colak, A; Demirpence, M; Girgin, E; Aslan, F D; Taylan, A; Ceylan, C.

Afiliação

Yasar HY; Endocrinology, Tepecik Research and Training Hospital, Turkey.
Colak A; Biochemistry, Tepecik Research and Training Hospital, Turkey.
Demirpence M; Endocrinology, Tepecik Research and Training Hospital, Turkey.
Girgin E; Biochemistry, Tepecik Research and Training Hospital, Turkey.
Aslan FD; Biochemistry, Tepecik Research and Training Hospital, Turkey.
Taylan A; Rheumatology, Tepecik Research and Training Hospital, Turkey.
Ceylan C; Hematology,Tepecik Research and Training Hospital, Turkey.

Acta Endocrinol (Buchar) ; 18(4): 466-473, 2022.

Article em En | MEDLINE | ID: mdl-37152878

Palavras-chave

cardiotrophin-1; cardiovascular risk; hyperandrogenemia; inulin resistance; polycystic ovary synrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Acta Endocrinol (Buchar) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google